Dy. Manager /Manager Treasury

Role Overview: You will be collaborating to manage treasury and banking operations across multi-entity environments, term loans, working capital facilities, and daily fund management at Jubilant Pharmova Limited in Noida. Your role will require demonstrated expertise in coordinating with banks and internal stakeholders for financial planning, compliance, and audit readiness. Key Responsibilities: - Planning and coordination with various banks and intra company for JGL and API businesses - Management of Term Loan and Working Capital, including servicing, renewals, and related compliances, as well as daily fund balances and WCDL utilisations - Checking interest rates with various banks, funding of interest - Resolving BRS and creating MIS reports for bank balances, working capital, and term loan balances with circulation - Preparing stock statements and conducting stock audits - Coordinating with intra-company for projections, FFR, and Due diligence - Liaising with secretarial for related activities - Coordinating intra-Company transfer letters and with the bank custodian of bank documents - Handling audit-related matters with respect to treasury and banking, and coordinating with Banks for Bank signatories Qualification Required: - MBA Finance/ Master of Commerce Additional Details: Jubilant Bhartia Group is a global conglomerate founded by Mr. Shyam S Bhartia and Mr. Hari S Bhartia with a strong presence in diverse sectors like Pharmaceuticals, Contract Research and Development Services, Proprietary Novel Drugs, Life Science Ingredients, Agri Products, Performance Polymers, Food Service (QSR), Food, Auto, Consulting in Aerospace, and Oilfield Services. The group has four flagship companies - Jubilant Pharmova Limited, Jubilant Ingrevia Limited, Jubilant FoodWorks Limited, and Jubilant Industries Limited, with a global workforce of around 43,000 employees. Jubilant Pharmova Limited, formerly Jubilant Life Sciences Limited, is involved in various businesses including Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, Contract Research Development and Manufacturing Organisation (CRDMO), Generics, and Proprietary Novel Drugs businesses. ,